Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

Gilead tests novel non-catalytic site integrase inhibitor GS-9822 in vivo

Feb. 22, 2017

Neurocognitive effects of cenicriviroc assessed in phase II study

Feb. 21, 2017

Novel HIV capsid inhibitors created at Gilead

Feb. 21, 2017

High virologic response rates seen with bictegravir regimen in phase II trial

Feb. 17, 2017

Hetero Research Foundation patents antiviral agents

Feb. 16, 2017

Phase III data show non-inferiority of doravirine and darunavir/ritonavir

Feb. 16, 2017

Research Council of Norway grant supports Bionor's development of Vacc-4x for HIV

Jan. 30, 2017

ViiV Healthcare UK identifies novel HIV integrase inhibitors

Jan. 30, 2017

First-in-human data for 10-1074 in HIV-1-infected individuals

Jan. 26, 2017

ViiV Healthcare UK presents novel HIV integrase inhibitors

Jan. 24, 2017

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...